FDA Approves Merck’s KEYTRUDA (pembrolizumab) for Previously Treated Patients with Recurrent or Metastatic Cervical Cancer Pharmaceutical Investing
Cutera Announces Expansion of FDA Indications for the truSculpt® Body Contouring System Longevity Investing
scPharmaceuticals Receives Complete Response Letter from the FDA for FUROSCIX Pharmaceutical Investing
Actinium Pharmaceuticals Announces Treatment of First Patient in Novel Combination Trial of Actimab-A Plus CLAG-M Pharmaceutical Investing
Corium Announces Issuance of Key U.S. Patent Covering Corplex Donepezil Transdermal System for Alzheimer’s Disease Biotech Investing
Medtronic Launches New Clinician Programmer for Deep Brain Stimulation Therapy Medical Device Investing
Wright Medical Announces FDA Premarket Approval for AUGMENT Injectable Bone Graft Medical Device Investing
Xanthic Announces the Installation of Manufacturing Equipment at its Strategic Partner’s Oregon Facility Cannabis Investing News
